NORTHBROOK, IL--(Marketwire - Mar 13, 2013) - Nanosphere, Inc. (NASDAQ: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today it has ...
Techcyte has been named 2025 Infectious Disease Testing Solution of the Year by the BioTech Breakthrough Awards, a leading ...
The aim of the present prospective study was to assess the validity of the Gram stain–AOLC test for the diagnosis of CRBI in HSCT recipients with nontunnelled CVCs, using the DTP/clinical criteria as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results